Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Sonoma Pharmaceuticals, Inc.

TRADE

NASDAQ: SNOAHealthcare / Drug Manufacturers - Other / USA
1.54+0.02+1.32%Vol 69 4751Y Perf -66.44%
Oct 17th, 2018 16:00
BID1.50 ASK1.63
Open1.52 Previous Close1.52
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.00 
Analyst Rating
Moderate Buy 1.67
Potencial %
224.68 
Finscreener Ranking
★★★★+     60.02
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
★★★★     57.40
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★★+     46.82
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)10 
Earnings Rating
Neutral
Price Range Ratio 52wk %
4.99 
Earnings Date
8th Nov 2018

Today's Price Range

1.501.64

 

52wk Range

1.315.92

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Month
0.00%
3 Months
-35.02%
6 Months
-60.41%
1 Year
-66.44%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
SNOA1.540.02001.32
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.80
Current Ratio 4.00
Long Term Debt to Total Capital 0.01
Total Debt to Equity 0.04
Interest Coverage -339.00
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin42.30
EBIT Margin-82.80
EBITDA Margin-79.90
Pre-tax Profit Margin-75.20
Profit Margin-88.82
ValuationValueIndustryS&P 500US Markets
PE Ratio 2.70
PB Ratio 0.87
PS Ratios 0.85
Price to Cash Flow 10.50
Price to Free Cash Flow -1.30
Cash Flow Per Share -2.17
Price to Tangible Book0.87
Book Value per Share1.96
Enterprise Value (in ths.)3 770
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-29.52
ROE last 12 Months -90.20
Return on Assets (5Y Avg) -19.82
ROA last 12 Months -72.18
Return on Capital (5Y Avg) -24.99
ROC last 12 Months -89.95
Return on invested Capital Q -24.16
Return on invested Capital Y-77.13
Assets Turnover0.50
Receivables Turnover5.30
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)12 867
Revenue per Share 1.99
Revenue Growth 3 Years 0.90
Revenue Growth 5 Years 2.47
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2019--0.55-
Q04 2018-0.65-0.93-43.08
Q03 2018-0.63-0.73-15.87
Q02 2018-0.75-0.6710.67
Q01 2017--0.61-
Q04 2016--0.16-
Q03 2016--0.19-
Q02 2016-0.14-0.1121.43
Earnings Per EndEstimateRevision %Trend
3/2018 QR-0.650.00-
3/2018 QR-0.6014.29Positive
3/2019 FY-2.000.00-
3/2019 FY-2.200.00-
Next Report Date8th Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume69 475
Shares Outstanding (in ths.)6 480
Trades Count183
Dollar Volume93 304
Avg. Volume97 833
Avg. Weekly Volume79 794
Avg. Monthly Volume212 629
Avg. Quarterly Volume96 646

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

33%67%

Bearish Bullish

67%33%

Bearish Bullish

69%31%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News

x